Share the article!
The article "OLA-Simple: a software-guided HIV-1 drug resistance test for low-resource laboratories" is now available online.
Please stay at home
Nuttada Panpradist, a Thai Ph.D. student in Bioengineering at the Department of Bioengineering, University of Washington, USA will visit PHPT on Monday, 2 March 2020 to discuss research a development of tests for HIV drug resistance and possibly for the diagnosis of other infections.
Dr. Taraneh Shojaei, Regional Counsellor in Global Health, South-East Asia, based at the French Embassy in Thailand visited the PHPT research collaboration in Chiang Mai on Tuesday, 11 February 2020.
She met with Prof. Sakorn Pornpraset, Dean of the Faculty of Associated Medical Sciences (AMS), Chiang Mai University (CMU), researchers and staff to discuss PHPT research operations and review the status of the project “Implementation of user-friendly HIV testing and counseling services in Thailand provinces” supported by a grant from Expertise France-Initiative 5% . She also visited MAP Foundation to meet Hark Murng and discuss health issues faced by the migrant population.
Pra-ornsuda Sukrakanchana and Gonzague Jourdain, IRD PHPT U174, visiting the DRIVE projects (ANRS12299 and ANRS 12353) implemented with Hai Phong Pharmacy and Medicine University, in Hai Phong, Vietnam on 10 December 2019. These projects aim at evaluating interventions to reduce the burden of HIV and HCV infections among intravenous drug users in Hai Phong.
Many thanks to the project team also presented DRIVE-C, a study to assess the effectiveness of a model of hepatitis C screening and integrated care, targeting people who inject drugs (NCT03537196).
Prof. Pan-Chyr Yang, a Professor of the Department of Internal Medicine at National Taiwan University, and Prof. Jean-Marc Egly, a member of the IRD Scientific Committee and visiting professor at National Taiwan University, visited PHPT office on Tuesday 8 October 2019. They met PHPT researchers and as well as the PHPT clinical research platform team and they also visited Faculty of Associated Medical Sciences, Chiang Mai University to meet with Prof. Sakorn Pornprasent, Dean of Faculty of Assoicated Medical Sciences, Chiang Mai University and team for a discussion about possible collaborations between the faculty of AMS and National Taiwan University.
at The Empress Hotel
199/42 Chang Klan Road,
Chiang Mai, Thailand
The Faculty of Associated Medical Sciences, Chiang Mai University, and the international research unit 174/PHPT of the French National Research Institute for Sustainable Development (IRD) are organizing a symposium addressing ‘Elimination of Human Immunodeficiency Virus and Chronic Viral Hepatitis in South–East Asia: How close are we?”. It will be an opportunity to celebrate the 75 years of the French National Research Institute for Sustainable Development.
Infectious diseases are still a major cause of mortality and morbidity in Asia. One of the targets of the Sustainable Development Goals (SDGs) for 2030 includes the end of the HIV/AIDS epidemic and the fight against viral hepatitis. The World Health Organization has proposed targets to be reached to declare the elimination of the transmission of HIV and viral hepatitis. Even if Asia is facing a rapid rise in non-communicable diseases (diabetes, hypertension, cancer ...), several infectious diseases are still putting enormous pressure on populations and health care systems.
Diagnosis and prevention tools and even treatment already exist but are not used optimally.
However, strategies to identify those who could benefit from these treatments are yet to be defined. Despite the availability of new techniques (rapid tests, GeneXpert), the implementation of screening programs proves difficult. The "Test and Treat" strategy has emerged and now offers hope for the elimination of some chronic infections. New tools such as Pre-Exposure Prophylaxis (PrEP) are promising but remain often not accessible by those who should use them. When it comes to therapeutic strategies, the situation differs for each infection. Although there is no vaccine for hepatitis C, there are now drugs that can cure the infection. In the case of hepatitis B, there is an effective vaccine, but no treatment can cure the infection. For HIV, there is no vaccine and no cure, but treatments can efficiently control the infection. There is still a need for improvement with regard to costs, need for refinement of health policies, and reach the end for the elimination of discrimination towards infected persons.
The collaborative research program PHPT aims to develop new strategies to contribute to the elimination of infectious diseases. Current studies focus on the prevention of perinatal transmission of HBV (iTAP-1 and 2), and the early diagnosis of HIV infection in young adults in Southeast Asia (www.napneung.net).
The objectives of this symposium are:
The symposium is supported by the French National Research Institute for Sustainable Development (IRD), the French National Agency for Research on AIDS and Viral Hepatitis (ANRS), and Gilead Sciences, Inc.
The symposium will be attended by about 120 researchers and health care professionals, practitioners from the region from Thailand, Cambodia, France, Indonesia, Lao-PDR, Malaysia, Myanmar, and Vietnam, as well as representatives of the communities affected by these diseases. Experts from the Region, USA and Europe will share their knowledge and expertise.
Jacques Lapouge, French Ambassador in Thailand; Fabian Forni, Counsellor for Culture and Cooperation, and Thomas Baude, Honorary French Consul in Chiang Mai visited PHPT and Faculty of Associated Medical Sciences, Chiang Mai University on Friday 8 February 2019. They met Sakorn Pornprasert, Dean of the Faculty of Associated Medical Science, Chiang Mai University, Gonzague Jourdain and several researchers and staff of the PHPT-AMS research collaboration team.
At PHPT, we design and test methods to improve the Prevention and Treatment of HIV infection and virus-associated cancers in Southeast Asia.
This is a collaboration between Chiang Mai University (CMU) and Institut de Recherche p our le Développement (IRD) for research in HIV/AIDS, hepatitis B (HBV), hepatitis C (HCV), human papillomavirus (HPV), and tuberculosis, along with hospitals and other institutions in Thailand, Laos, Cambodia, and Myanmar.
HeBOOC, a free online training course
|HeBOOC, a free online training course on hepatitis B clinical management (English version)|
|File Size:||256 kb|